載入...
USP21 regulates Hippo pathway activity by mediating MARK protein turnover
The Hippo pathway, which acts to repress the activity of YAP and TAZ trancriptional co-activators, serve as a barrier for oncogenic transformation. Unlike other oncoproteins, YAP and TAZ are rarely activated by mutations or amplified in cancer. However, elevated YAP/TAZ activity is frequently observ...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609986/ https://ncbi.nlm.nih.gov/pubmed/28969054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19322 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|